In this private feed episode of The Metabolic Link, brain tumor researcher Dr. Adrienne Scheck shares groundbreaking science on using therapeutic ketogenic diets to treat cancer. She spotlights metabolic dysfunction as a key target, arguing that while cancer cells are typically addicted to glucose, most normal cells can thrive on ketones.

In preclinical studies, Dr. Scheck demonstrates ketogenic diets slow tumor growth, enhance chemotherapy and radiation, reduce inflammation, normalize gene expression, and empower the immune system against cancer. Her lab unravels the pleiotropic mechanisms beyond glucose restriction - epigenetic changes like histone acetylation, DNA methylation, and microRNA expression.

Excitingly, Dr. Scheck reveals unpublished data on patient experiences using the ketogenic diet for the ruthless pediatric brain cancer DIPG. Though still anecdotal, their stories suggest quality of life benefits and potential synergy prolonging life alongside standard therapies. She makes an urgent call for clinical trials, proposing ketogenic diets as the missing adjuvant to improve outcomes and reduce side effects for brain tumor patients.

Watch or listen to the full episode for FREE by signing up for a 7-day trial of The Metabolic Initiative: https://membership.metabolicinitiativ...

Thanks for listening! Follow us on social media @metabolichealthsummit for the latest science on metabolic health and therapy.

Disclaimer: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have."